Carregant...
Pathogenic Upregulation of Glial Lipocalin-2 in the Parkinsonian Dopaminergic System
Lipocalin-2 (LCN2) is a member of the highly heterogeneous secretory protein family of lipocalins and increases in its levels can contribute to neurodegeneration in the adult brain. However, there are no reports on the role of LCN2 in Parkinson's disease (PD). Here, we report for the first time...
Guardat en:
| Publicat a: | J Neurosci |
|---|---|
| Autors principals: | , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Society for Neuroscience
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6601774/ https://ncbi.nlm.nih.gov/pubmed/27194339 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.4261-15.2016 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|